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II. Abstract 
When a traumatic skeletal muscle injury occurs, such as crushing, contusion, laceration, or 
freezing, the body must mount an inflammatory response in order to clear muscle debris and 
fully regenerate the damaged muscle. This response is made up primarily of an innate immune 
response, which is amplified by the release of pro-inflammatory cytokines and chemokines and 
leads to the activation of several specific myeloid cell populations. The neutrophil, the first 
myeloid cell to infiltrate injured muscle, is attracted by the cytokines IFN-γ and TNF-α and the 
chemokines CXCL1 and CXCL5. However, the timing and magnitude of CXCL1 and CXCL5 
signaling following muscle injury have not been carefully examined. Using a freeze injury model 
to induce a traumatic injury to muscle and real-time PCR, we showed that CXCL1 and CXCL5 
expression is rapidly upregulated, within 60 minutes and 3 hours, respectively, in mouse tibialis 
anterior (TA) muscles following injury. This finding serves as a starting point in the 
characterization of pro-inflammatory chemokines’ impacts on the muscle injury inflammatory 
response. 
 
III. Introduction 
 The human body contains three types of muscle tissue: cardiac, smooth, and skeletal. 
Cardiac muscle, as the name implies, is found in the heart and powers the organ’s repetitive 
cycles of contraction and relaxation as it pumps blood through the body. Smooth muscle is 
located in many areas of the body that are lined with an epithelium, such as the GI tract, and 
controls a multitude of essential body functions without conscious effort. And finally, skeletal 
muscle, the type of tissue most commonly associated with the term “muscle”, is composed of 
force-generating units that support locomotion and allow us to do work. The interest of this study 
lies in the last type of muscle tissue. 
Most skeletal muscles are located superficially in the body and are stressed daily by the 
many tasks that we ask them to perform, as well as by a multitude of unexpected physical 
traumas, such as crushing, contusion, laceration, or freezing. These types of muscular injuries are 
common in humans and can have long-lasting effects on the muscle’s integrity. When traumatic 
muscle injuries do occur, the tissue mounts an inflammatory response in order to fully regenerate 
the damaged muscle. In general, inflammation is simply the immune system’s reaction to a 
stimulus, a damaged muscle in this case. Although often viewed as negative, inflammation is 
actually a necessary component of skeletal muscle’s acute response to injury, as its processes are 
essential for the eventual restoration of the tissue’s form and function (Tidball 2012). In order for 
the muscle to recover fully, damaged fibers must be broken down, removed, and replaced by 
previously undifferentiated cells called satellite cells (Summan 2006). Attenuation of the 
inflammatory response can result in prolonged clearance of necrotic (dead) myofibers and 
increased accumulation of fat in the muscle post-injury (Summan 2006). If the muscle heals 
improperly, its functional recovery can be incomplete, it can have a tendency to become injured 
again, and scar tissue may form (Huard et. al 2002), similar to what occurs in diseased muscle 
with chronic inflammation.  
Skeletal muscle's inflammatory response to a sterile, traumatic injury is made up 
primarily of an innate immune response (Tidball 2012). Innate immunity is a protective system 
that is present at birth and does not have to be acquired through contact with a foreign body. It 
allows organisms to mount an immediate defense against invaders, but has no lasting memory of 
the attacker and treats all foreign bodies in much the same way. At the beginning of this innate 
response following a traumatic muscle injury, T-helper cells, cells that work to increase the 
activation of other immune cells, are activated in response to the damaging of the tissue.  These 
T-helper cells then release a group of pro-inflammatory cytokines called Th1-type cytokines that 
help to amplify the immune signal. This signal produces a response by several specific myeloid 
cell populations, which are activated and attracted to the site of the injured muscle (Tidball 
2010). Myeloid cells are secretory cells that, when activated, release an array of soluble 
molecules that affect viability and transcriptional activity in regenerating muscle cells (Tidball 
2010). The first of these populations, and the one that is relevant to this study, is the neutrophil, a 
phagocytotic (cell-engulfing) cell population that infiltrates the damaged muscle tissue and 
begins to break down cellular debris.  The influx of neutrophils is caused by the cleavage of 
soluble proteins in the complement system following injury (Tidball 2012) as well as attraction 
by the pro-inflammatory cytokines IFN-γ and TNF-α, and the pro-inflammatory chemokines 
CXCL1 and CXCL5, all of which are released by activated T-helper cells (Tidball 2010). 
Previously, levels of CXCL1 have been found to be significantly increased in mouse 
EDL and soleus muscles after just a 30 min treadmill protocol (Nedachi 2008). ELISA 
experiments by the same group found secretions of both CXCL1 and CXCL5 to be increased 
within 1 hour of electric pulse stimulation in vitro, and these increases were accompanied by 
rises in the concentrations of CXCL1 and CXCL5 mRNAs (Nedachi 2009). However, beyond 
these limited time point studies, the time at which these signals first appear and how long they 
persist following induction of a traumatic skeletal muscle injury is not known. This is important 
knowledge to our understanding of the impacts of CXCL1 and CXCL5 signaling and the 
chemokines’ effects on the muscle injury inflammatory response overall. 
Through the use of a freeze injury model and real-time polymerase chain reaction 
(qPCR), we evaluated the expression of the CXCL1 and CXCL5 genes at various time points 
after injury induction. Based on the work of the Nedachi group, I hypothesized that CXCL1 
would be significantly upregulated 30 minutes post-injury and CXCL5 would be upregulated 1 
hour after. 
  
 
IV. Materials and Methods 
Animals 
Twenty-one female C57BL/6 (wildtype) mice were acquired from Jackson Laboratories 
(Bar Harbor, ME). Mice were housed in groups of 3-5 and had access to phytoestrogen-free 
rodent chow (Harlan-Teklad; Indianapolis, IN) and water ad libitum. The room was maintained 
on a 12:12 light:dark cycle.  
Experimental Design 
 A freeze injury was induced to the tibialis anterior (TA) muscles of twenty-one mice in 
the study, with the exception of a control group (3 mice). Then, at immediate, 30 minute, 1 hour, 
3 hour, 5 hour, and 12 hour time points (n=3 per time point), the TA muscles were harvested for 
analysis. Thirty minutes were counted from the time that the steel probe was pressed to the TA 
muscle until the time that the lethal pentobarbital overdose was administered. The different 
recovery periods were used in an attempt to identify when inflammatory chemokine gene 
expression changes first occur and to what extent. 
Freezing Injury and TA muscle excision 
The mice were anesthetized via inhalation with 1.75% isoflurane mixed with oxygen at a 
flow rate of 200 ml/min. Body temperature was maintained using a water-re-circulating heatpad, 
and the lateral and anterior surfaces of the hindlimbs were shaved and prepared aseptically using 
betadine solution and 70% ethanol. Each mouse received 0.1333 mg/kg body weight 
buprenorphine subcutaneously. Then, a 1.5 cm incision was made through the skin to expose the 
TA muscle.  A steel probe with a rounded tip of 6 mm diameter was cooled to the temperature of 
dry ice for 30 minutes as previously described in the scientific literature (Warren 2004). The 
probe was applied to the muscle mid-belly for 10 seconds to induce a freeze injury. Mice in the 
immediate, 30 minute, and 1 hour groups remained under anesthesia until muscle harvest. For 
the mice in the 3 hour, 5 hour, and 12 hour groups, 6-0 silk suture and vetbond were used to 
close the incision, and the site was treated with hydrogen peroxide. Each mouse in these groups 
also received 0.1333 mg/kg body weight buprenorphine subcutaneously approximately 5 minutes 
after withdrawal from isoflurane anesthetic (Moran 2006). 
For harvesting, mice were euthanized via intraperitoneal injection with a 200 mg/kg body 
weight overdose of pentobarbital sodium (Diamondback Drugs; Scottsdale, AZ) and both TA 
muscles were excised. TA muscles were flash-frozen in liquid nitrogen and put in the -80°C 
freezer for long-term storage. All protocols and animal care procedures were approved by the 
University of Minnesota Institutional Animal Care and Use Committee (IACUC). 
RNA Isolation 
TA muscle samples in 2 mL microcentrifuge tubes were removed from the -80°C freezer 
and placed on ice for 10 minutes to thaw. Each muscle was then placed into a small plastic Petri 
dish and cut into 4 or 5 pieces using a sterilized forceps and a razor blade. The muscle pieces 
were returned to their tubes and 1 mL of TRIzol reagent (Ambion by Life Technologies; Eugene, 
OR) was added to each tube. The TRIzol was kept on ice throughout the isolation protocol. A 
Tissue Tearer® (Biospec Products; Bartlesville, OK) was then used to homogenize each muscle 
at high speed for 30 seconds. If small pieces could still be observed in the tube, the tissue was 
subjected to 15 more seconds of homogenization until muscle material was no longer visible. 
After each muscle, the Tissue Tearer® was cleaned by running it at high speed in a beaker of 
10% bleach solution and 3 different beakers of distilled water. The homogenizer was run for 30 
seconds in the the 10% bleach and two of the water beakers, and for 20 seconds in the third 
beaker of water. 
After the muscle tissue was homogenized, RNA was isolated by following instructions in 
the commercially available RNeasy® Kit (Qiagen; Alameda, CA). The RNA was then quantified 
by placing 1.5 µL in the Nanodrop® ND-1000 spectrophotometer (Thermo Scientific; Waltham, 
MA) and recording the RNA concentrations (ng/µL). The ratio of spectrophotometric absorbance 
at 260 nm to that at 280 nm was used to assess RNA purity. A ratio range of 1.9-2.1 was desired 
for use in future cDNA synthesis and Real-time PCR (qPCR). 
cDNA synthesis 
cDNA synthesis was performed using a commercially available high-capacity RNA to 
cDNA kit (Applied Biosystems by Life Technologies; Eugene, OR). The kit contained 
oligonucleotides, cDNA master mix, and reverse transcriptase enzyme. 1 µg of RNA was used 
for each sample and the manufacturer’s protocol was followed. 
Real-time PCR (qPCR) 
Two hundred nanograms cDNA from each sample were used in Taqman Fast-Advanced 
master mix (Life Technologies) to perform qPCR gene expression assays, following the 
manufacturer’s protocol. The expression of the pro-inflammatory chemokines CXCL1 and 
CXCL5 was used to assess differences between the control and freeze-injured muscles.  Hprt and 
Hsp90ab1 (Life Technologies) were used as housekeeping genes to compare relative gene 
expression increases between the control and experimental groups. The comparative threshold 
(CT) method was used to calculate relative concentrations. Samples were assayed on an Applied 
Biosystems 7900HT Fast Real-Time PCR System (Applied Biosystems). 
Statistics 
Differences in gene expression among groups of mice were analyzed using the Relative 
Expression Software Tool (REST). An α-level of 0.05 was used for significance. 
V. Results 
Evaluation of pro-inflammatory chemokine expression 
 Real-time polymerase chain reaction (qPCR) was used to examine how long after freeze 
injury significant increases in the expression of the pro-inflammatory chemokines CXCL1 and 
CXCL5 occur, as well as the magnitude of the gene upregulation. When compared to the control 
group, we found CXCL1 gene expression increases to be highly significant (p≤0.001) at 1 and 3 
hours post-injury and significant (p≤0.05) at the 5 hour time point (Figure 1A). The magnitude 
of the expression changes was greatest at 3 hours after injury, with a mean expression 325 times 
greater than the control. CXCL5  expression was increased at 3, 5, and 12 hours after freeze 
injury (Figure 1B). The magnitude of the changes was much larger than in CXCL1, as the mean 
expression at the 12 hour time point was 23,943 fold greater than the control muscles. 
   
 
VI. Discussion 
In this study, we showed that traumatic skeletal muscle injury produces a rapid 
upregulation of CXCL1 and CXCL5 gene expression, beginning as early as 1 hour after 
injury induction. These early changes are in relative agreement with data from past studies 
using treadmill running (Nedachi 2008) and electrical pulse stimulation (Nedachi 2009), 
which first found increases in chemokine-related measures at 30 minutes and 1 hour, 
respectively. However, it should be noted that CXCL1 and CXCL5 gene expression increases 
were not found in this study at either the immediate harvest time point or the 30 minute time 
point. This implies that these pro-inflammatory chemokines are not instantaneously released 
from the muscle when injured and that there is a time delay between injury and attraction of 
neutrophils to begin phagocytosis. 
 The main implication of this finding is that it provides us with clues about just how soon 
after skeletal muscle injury the immune signal amplification occurs and neutrophils begin to 
be attracted by pro-inflammatory chemokines to the site of damage. Future directions include 
increasing the number of mice in each group to reach an adequate sample size for 
publication, performing fluorescent immunohistochemistry to quantify positive signals 
and/or assess the localization of the chemokines within the muscle tissue, and running 
Western blots to identify the time delay between the increase in CXCL1 and CXCL5 gene 
expression and increased protein levels in the muscle. The Western blot experiments are 
particularly important, since it is the CXCL1 and CXCL5 proteins, not the mRNAs they are 
translated from, that attract neutrophils to the site of injury. 
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